Sat, April 2, 2011
Fri, April 1, 2011
Thu, March 31, 2011
Wed, March 30, 2011
Tue, March 29, 2011
Mon, March 28, 2011
Sun, March 27, 2011
Fri, March 25, 2011
Thu, March 24, 2011
Wed, March 23, 2011
Tue, March 22, 2011
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ]: Market Wire
30 p.m. ET
Sun, March 20, 2011
Fri, March 18, 2011
Thu, March 17, 2011
Wed, March 16, 2011
Tue, March 15, 2011
Mon, March 14, 2011
Sun, March 13, 2011
Sat, March 12, 2011
Fri, March 11, 2011

Gilead to Offer Senior Notes

  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/03/23/gilead-to-offer-senior-notes.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) today announced its intention to offer, subject to market and other conditions, senior notes under a shelf registration statement on file with the Securities and Exchange Commission. The interest rate, the maturity dates and other key terms of the offering are to be determined at the time of pricing.

Gilead intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of certain indebtedness and the repurchase of outstanding common stock pursuant to the companya™s authorized share repurchase program.

Bank of America Merrill Lynch, J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering. The offering of the securities is being made only by means of a prospectus supplement and the accompanying base prospectus, which is part of Gileada™s effective shelf registration statement filed with the Securities and Exchange Commission, copies of which may be obtained from:

Bank of America Securities
LLC

J. P. Morgan Securities LLC

Morgan Stanley & Co.
Incorporated

Prospectus Department

383 Madison Avenue

180 Varick Street

100 West 33rd Street

New York, NY 10179

New York, NY 10014

New York, NY 10001

Attention: Investment Grade
Syndicate Desk

Attention: Prospectus
Department

800 294 1322

212 834 4533

866 718 1649

Before you invest, you should read the prospectus supplement and the accompanying base prospectus in Gileada™s effective registration statement and other documents Gilead has filed with the Securities and Exchange Commission for more complete information about Gilead and this offering. You may get these documents for free by visiting the Securities and Exchange Commissiona™s website at [ www.sec.gov ].

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

Forward-Looking Statement

This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that are subject to risks, uncertainties and other factors, including the current market demand for these types of securities and the securities of Gilead and the negotiations between Gilead and the underwriters. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Other risks that could impact the offering are described in detail in Gilead's Annual Report on Form 10-K for the year ended December 31, 2010 as filed with the U.S. Securities and Exchange Commission, and may be updated by the risk factors set forth in any subsequent filing by Gilead with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead and Gilead assumes no obligation to update any such forward-looking statements.